# Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

> **NCT02458079** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 32 (actual)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** Pentoxiphylline
- **DRUG:** Stool microbiota transplantation

## Key facts

- **NCT ID:** NCT02458079
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-01
- **Primary completion:** 2016-07-27
- **Final completion:** 2016-07-27
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458079, "Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02458079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*